Selection of Antihypertensive Drugs in Hypertensive Patients with Diabetes Mellitus: In Pohang-Gyeongju Primary Care Research Network.
- Author:
Chul Won JANG
1
;
Ki Hoon HA
;
Nak Jin SUNG
;
Dong Wook LEE
;
Kyung Rae CHO
;
Sook Heong JUNG
;
Seok CHOI
;
Jae Man KI
;
Sung Woo KIM
;
Kyung Ja CHOI
;
Dong Ik KIM
;
Joon Seok SONG
;
Young Kyu CHOI
;
Hee Nam SONG
;
Ki Heum PARK
Author Information
1. Department of Family Medicine, Dongguk University College of Medicine, Korea. Parkkh@dumc.or.kr
- Publication Type:Original Article
- Keywords:
diabetes mellitus;
hypertension;
angiotensin converting enzyme inhibitor;
angiotensin II type 1 receptor blocker
- MeSH:
Antihypertensive Agents*;
Calcium Channels;
Diabetes Mellitus*;
Humans;
Hypertension;
Incidence;
Peptidyl-Dipeptidase A;
Physicians, Family;
Prescriptions;
Primary Health Care*;
Private Practice;
Receptor, Angiotensin, Type 1
- From:Journal of the Korean Academy of Family Medicine
2006;27(9):706-712
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Angiotensin converting enzyme inhibitor or Angiotensin II type 1 receptor blocker is usually recommended for hypertensive patients with diabetes mellitus. No reports have been made on antihypertensive agents prescribed for these patients in private practice. METHODS: During a one month period of December 2004, 169 hypertensive patients with diabetes mellitus on their prescribed antihypertensive agents by ten family physicians were analyzed. The influencing factors for such prescriptions were analyzed by directly visiting each physicians who prescribed them. RESULTS: A total of 21 antihypertensive agents were prescribed by these family physicians. Single calcium channel blocker therapy was the most common with 55 cases (32.5%), followed by 20 cases (11.8%) of single angiotensin converting enzyme inhibitor therapy and 16 cases of single therapy of Angiotensin II type 1 receptor blocker. The low frequency of prescribing the Angiotensin II type 1 receptor blocker was due to insufficient effect (7), lack of information (5), resistance from the patients from changing the medications (4) and expensive costs (4). CONCLUSION: In prescribing antihypertensive agents for patients with diabetes mellitus, angiotensin converting enzyme inhibitor or Angiotensin II type 1 receptor blocker were chosen less. In order to decrease the incidence of complications in these patients, such agents should be prescribed more.
